Amplify Weight Loss Drug & Treatment ETF (THNR)
25.07
-0.22
(-0.87%)
USD |
NYSEARCA |
Sep 16, 16:00
Price Chart
Key Stats
| Net Expense Ratio | Discount or Premium to NAV | Total Assets Under Management | 30-Day Average Daily Volume |
|---|---|---|---|
| 0.59% | -0.14% | 5.775M | 1756.90 |
| Weighted Average Dividend Yield | Turnover Ratio (Generic) | 1 Year Fund Level Flows | Max Drawdown (Since Inception) |
| 1.57% | 70.00% | 617871.0 |
Basic Info
| Investment Strategy | |
| The Fund seeks investment results that generally correspond to the performance of the VettaFi Weight Loss Drug & Treatment Index. It invests at least 80% of its net assets in securities that comprise the Index which is comprised of global companies who are manufacturers in the GLP-1 agonist pharmaceutical business. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Large Cap Growth |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Sector Healthcare |
| Peer Group | Global Health/Biotechnology Funds |
| Global Macro | Equity Industry Sector |
| US Macro | World Sector Equity Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Global Health/Biotechnology Funds |
| Fund Owner Firm Name | Amplify ETFs |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of September 17, 2026.
Asset Allocation
As of August 31, 2026.
| Type | % Net |
|---|---|
| Cash | 0.24% |
| Stock | 99.28% |
| Bond | 0.27% |
| Convertible | 0.00% |
| Preferred | 0.00% |
| Other | 0.20% |
Basic Info
| Investment Strategy | |
| The Fund seeks investment results that generally correspond to the performance of the VettaFi Weight Loss Drug & Treatment Index. It invests at least 80% of its net assets in securities that comprise the Index which is comprised of global companies who are manufacturers in the GLP-1 agonist pharmaceutical business. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Large Cap Growth |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Sector Healthcare |
| Peer Group | Global Health/Biotechnology Funds |
| Global Macro | Equity Industry Sector |
| US Macro | World Sector Equity Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Global Health/Biotechnology Funds |
| Fund Owner Firm Name | Amplify ETFs |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |